Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) announced a dividend on Tuesday, January 14th, NASDAQ Dividends reports. Stockholders of record on Friday, March 7th will be given a dividend of 0.1072 per share on Thursday, March 27th. The ex-dividend date of this dividend is Friday, March 7th.
Elekta AB (publ) Stock Performance
Shares of Elekta AB (publ) stock traded up $0.21 during trading on Wednesday, reaching $5.75. The company’s stock had a trading volume of 1,270 shares, compared to its average volume of 9,015. The company has a 50-day moving average price of $5.73 and a two-hundred day moving average price of $6.05. Elekta AB has a fifty-two week low of $5.25 and a fifty-two week high of $8.24. The firm has a market cap of $2.21 billion, a PE ratio of 23.00 and a beta of 1.25. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60.
Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) last announced its earnings results on Friday, February 21st. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. The business had revenue of $416.86 million during the quarter, compared to analysts’ expectations of $435.89 million. On average, analysts forecast that Elekta AB will post 0.36 EPS for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on Elekta AB (publ)
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Read More
- Five stocks we like better than Elekta AB (publ)
- Which Wall Street Analysts are the Most Accurate?
- Is Advanced Micro Devices Stock Slide Over?
- How to Find Undervalued Stocks
- Lemonade’s Q4 Surge: Has This AI-Powered Insurer Turned a Corner?
- Top Biotech Stocks: Exploring Innovation Opportunities
- 2 Energy Stocks to Play Both Sides of Tariff Uncertainty
Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.